Lv3
346 积分 2024-12-16 加入
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
1个月前
已关闭
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
2个月前
已完结
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
2个月前
已完结
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
2个月前
已完结
A randomized, double-blind, placebo-controlled, multi-center, phase III clinical trial to investigate silodosin in the treatment of benign prostatic hyperplasia
3个月前
已完结
Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
3个月前
已完结
An update on drug–drug interactions associated with proton pump inhibitors
5个月前
已完结
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
5个月前
已完结
Systemic and Local Pharmacokinetics of DARE-BV1, a Novel Single Dose 2% Clindamycin Phosphate Vaginal Gel for the Treatment of Bacterial Vaginosis
6个月前
已完结
Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay
6个月前
已完结
皖公网安备34019202002308
